Gwangdong Pharmaceutical Appoints Lee Seungjae as Head of Manufacturing Division
Quality and Production Management Expert with Experience at Major Domestic and Global Pharmaceutical Companies Including Abbott Korea and Humedix
Gwangdong Pharmaceutical announced on the 26th that it has appointed Executive Director Lee Seungjae as the new Head of the Manufacturing Division.
Lee Seungjae, Head of Production Division at Gwangdong Pharmaceutical. Gwangdong Pharmaceutical
View original imageThe company explained that this personnel decision is intended to promote internal talent to enhance organizational stability and to strengthen continuity across all manufacturing processes. Lee plans to focus on advancing the production management system and establishing a stable supply system for all product lines.
Lee earned both his bachelor's and master's degrees from the College of Pharmacy at Chung-Ang University. He began his career as a researcher at Dongwha Pharm and then led quality assurance at domestic and global pharmaceutical companies such as Abbott Korea and Humedix, building extensive experience in pharmaceutical manufacturing and quality control.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A Gwangdong Pharmaceutical official stated, "Based on his extensive on-site experience, we expect Lee to take the lead in improving the efficiency of manufacturing processes and enhancing quality competitiveness."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.